Danaher Corporation $DHR Stake Raised by American National Bank & Trust

Key Points

• American National Bank & Trust increased its Danaher stake by 229.2% in the third quarter, bringing its holdings to 8,835 shares valued at approximately $1.96 million. Institutional investors and hedge funds collectively own 79.05% of Danaher.
• Analyst sentiment remains favorable, with Danaher receiving a “Moderate Buy” consensus rating and an average price target of $235.23. Several firms recently raised their targets to between $250 and $255.
• Danaher reported quarterly EPS of $1.94, exceeding estimates, while revenue rose 5.5% year over year to $6.26 billion. The company also declared a quarterly dividend of $0.40 per share, equivalent to a 0.7% yield.

American National Bank & Trust increased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 229.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,835 shares of the conglomerate's stock after acquiring an additional 6,151 shares during the period. American National Bank & Trust's holdings in Danaher were worth $1,957,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of DHR. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $10,492,520,000. State Street Corp grew its stake in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate's stock valued at $6,345,529,000 after acquiring an additional 472,608 shares during the period. Wellington Management Group LLP grew its stake in Danaher by 10.4% in the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock valued at $3,108,031,000 after acquiring an additional 1,542,310 shares during the period. Jupiter Topco LLC purchased a new stake in Danaher in the 2nd quarter worth $1,456,317,000. Finally, Generation Investment Management LLP acquired a new position in Danaher during the second quarter worth $1,287,949,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on DHR. UBS Group initiated coverage on shares of Danaher in a research report on Wednesday, September 9th. They issued a "buy" rating and a $250.00 target price on the stock. The Goldman Sachs Group upped their price target on shares of Danaher from $210.00 to $250.00 and gave the stock a "buy" rating in a research report on Monday, September 21st. Weiss Ratings raised shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, September 16th. Royal Bank Of Canada lifted their price objective on Danaher from $215.00 to $250.00 and gave the stock an "outperform" rating in a report on Monday. Finally, Barclays increased their target price on Danaher from $230.00 to $255.00 and gave the company an "overweight" rating in a report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and an average price target of $235.23.

Danaher Price Performance

Shares of NYSE DHR traded up $2.77 during mid-day trading on Wednesday, reaching $218.38. The company's stock had a trading volume of 1,605,398 shares, compared to its average volume of 4,447,346. The stock has a 50-day moving average of $210.01 and a two-hundred day moving average of $194.05. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market capitalization of $153.52 billion, a P/E ratio of 38.73, a P/E/G ratio of 2.75 and a beta of 0.76. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the prior year, the company earned $0.77 EPS. Danaher's revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's dividend payout ratio (DPR) is currently 28.42%.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.